BridgeBio · 9 hours ago
Associate Director, Scientific Strategy & Publications
United States
Full-time
Remote
Lead/Staff, Director/Executive
$181K/yr - $229K/yr
4+ years expBridgeBio is a company focused on innovative solutions in biopharma, particularly in rare diseases. The Associate Director will lead scientific communications and publication strategies in endocrinology, ensuring alignment across various teams and developing impactful scientific messaging.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Develop and own the endocrinology scientific communications platform, including core narrative, lexicon, scientific messaging, and visual frameworks across disease state and asset-level content
Translate complex clinical and translational science into clear, compelling, and compliant scientific communications tailored to diverse audiences
Ensure consistency and alignment of scientific messaging across Medical Affairs, publications, congresses, and educational initiatives
Develop and oversee the integrated publication strategy and tactical publication plan for endocrinology programs
Lead execution of manuscripts, abstracts, posters, and presentations in collaboration with key internal teams including Clinical Development and Global Value and Health Economics, as well as with key opinion leaders
Manage publication vendors and ensure high-quality, timely delivery aligned with clinical and regulatory milestones
Lead development of scientific content for Field Medical, including slide decks, training materials, FAQs, and reactive resources
Oversee creation of congress materials, symposia content, booth messaging, digital educational tools, and external scientific presentations
Partner closely with Clinical Development, Regulatory, Global Value and Health Economics, and Commercial teams to align scientific communication strategy and execution
Support KOL engagement, advisory boards, and external scientific collaborations as needed
Represent BridgeBio at key scientific congresses and meetings, as appropriate
Qualification
Required
Advanced degree (PhD, MD, PharmD, or equivalent) in a scientific or medical discipline
4+ years of experience in scientific communications, medical affairs, publications, or related roles within pharma/biotech
Excellent medical writing skills in English is a requirement, as is a proven track record of authoring conference abstracts, scientific posters/presentation, manuscripts, and other scientific content
Proven ability to understand, interpret and communicate complex scientific data and to develop compelling scientific narratives
Exceptional communication and interpersonal skills are required to interact effectively with internal and external stakeholders
Highly organized, strategic thinker with the ability to manage multiple priorities in a fast-paced environment
Knowledge of publication ethics, GPP, and regulatory/MLR requirements
Preferred
Experience in endocrinology and/or rare disease is strongly preferred; direct experience in hypoparathyroidism is a significant plus
Benefits
401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$4.9BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Debt Financing· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
Leadership Team
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
Neil Kumar
CEO and Founder
Recent News
BioWorld Financial Watch
2026-01-17
Company data provided by crunchbase